ABSTRACT
INTRODUCTION
In mammals, three D-type cyclins have been identified: D 1 , D 2 , and D 3 . Most cells express D 3 and either D 1 or D 2 . In vitro, all three D-type cyclins are able to regulate the G 1 /S transition, as can be deduced from studies using antisense mRNA and antibody microinjection, and from overexpression experiments in cell lines [1] [2] [3] [4] [5] . Cyclin D 1 was the first D-type cyclin found in mammals [6, 7] . It is intriguing that increased cyclin D 1 levels have been found in two opposing cell cycle situations: cell proliferation [8] cell cycle arrest [9] . Also, cyclin D 1 protein levels were found to be up-regulated after apoptosis induction (e.g., by kainic acid treatment [10] or nerve growth factor deprivation [11] ). Several factors that are involved in G 1 /S cell cycle control, including the retinoblastoma protein [12] , p53 [13] , and p21 Cip1/WAF1 [14] are able to regulate cyclin D 1 synthesis, indicating that the different G 1 /S regulators are functionally linked. Recently, a new role for cyclin D 1 has been described as a ligand for the estrogen receptor (ER); cyclin D 1 competes with estrogen for ER binding and is able to activate the ER [15] .
Cyclins D 2 and D 3 have been implicated in proliferation and differentiation of several cell types, including granulosa cells, granulocytes, and megakaryocytes [5, 16, 17] . Although cyclin D 2 -deficient mice develop normally, cyclin D 2 -deficient female mice are sterile due to an inability of the granulosa cells to respond to FSH, whereas male mutants show testis hypoplasia [18] . Cyclin D 3 is strongly upregulated in leukemic cells induced to undergo differentiation and is highly expressed in quiescent, differentiating, and terminally differentiated cells. This suggests that cyclin D 3 has a role in promotion and, possibly, maintenance of the terminally differentiated state of some cell types [5] .
Primordial germ cells (PGCs) are the first known cells in the germ cell lineage and, upon arrival in the genital ridges, become gonocytes when they are enclosed in the seminiferous cords at Fetal Day (E) 12.5 [19, 20] . The gonocytes further proliferate until they are arrested in the G 0 / G 1 phase of the cell cycle at E16 [21] . In mice, gonocytes resume proliferation within a few days after birth and give rise to adult-type spermatogonia [20] . In the adult mouse testis, the undifferentiated spermatogonia are at the beginning of the spermatogenic lineage. These cells are on the basal membrane of the seminiferous tubules and can be subdivided according to their topographical arrangement into A single (A s ), A paired (A pr ), or A aligned (A al ) spermatogonia [22, 23] . The undifferentiated spermatogonia proliferate during part of the cycle of the seminiferous epithelium (stages X-II) and then become quiescent (stages III-VII) until most of the A al cells differentiate into differentiating type A 1 spermatogonia in stage VIII. After a series of divisions (A 2 to B), differentiating spermatogonia finally divide into spermatocytes that move toward a more adluminal position of the seminiferous tubules. After meiosis, the spermatocytes become round spermatids, which develop into elongating spermatids without further divisions.
Cyclin D mRNA has been found and localized in the mouse testis in various studies. Cyclin D 1 mRNA was found in Sertoli cells [24] . Cyclin D 2 mRNA was found in a few spermatogonia in the adult mouse, whereas cyclin D 2 was also present in Sertoli cells during testicular development [25] . Other studies, however, indicate low, if any, expression of cyclin D 2 in the mouse [24] or human [26] testis. Finally, cyclin D 3 mRNA was clearly observed in round spermatids and in Sertoli cells. Correspondingly, cy- clin D 3 protein was found in round spermatids, in addition to spermatogonia and spermatocytes in the mouse testis [27] . In the present study, the role of the D-type cyclins was further investigated through a detailed immunohistochemical analysis of the protein expression patterns in the developing, normal adult, and vitamin A-deficient (VAD) adult mouse testis.
MATERIALS AND METHODS

Animals and Fixation
A series of pregnant FvB/NiCO mice, E14 through E19, and a series of newborn mice (Day 1 through Day 4) were obtained from Broekman Instituut B.V. (Someren, The Netherlands) and were reared at the Central Laboratory Animal Institute, Utrecht, The Netherlands. Both fetal and newborn mice were decapitated, after which the testes were dissected.
For one experiment, VAD mice were obtained as described before [28] . Briefly, breeding pairs of Nc/Cpb-U mice (Central Laboratory Animal Institute) were fed a VAD diet (Teklad Trucking, Madison, WI) for at least 4 wk. Male weanlings received the same diet until they became VAD. Their body weights slightly decreased at the age of 14-16 wk. Some were given an i.p. injection of 1 mg all-trans retinoic acid in 16% dimethyl sulfoxide (DMSO; Sigma, St. Louis, MO). Twenty-four h after treatment, animals were killed by cervical dislocation, and testes were dissected.
Animals were housed in standard temperature-controlled conditions in a photoperiod of 14L:10D with food and water available ad libitum. The animal experimentation was approved by the Ethical Committee for Animal Experimentation of the Medical School, Utrecht University.
For histology and immunohistochemistry, testes were fixed in 10% neutral buffered formalin for 4 h and postfixed in a diluted Bouins solution (71% picric acid [0.9%], 24% formaldehyde [37%], 5% acetic acid) for 16 h at 4ЊC. Tissues were dehydrated and washed in 70% ethyl alcohol prior to embedding in paraffin (Stemcowax, Adamas Instruments, Amerongen, The Netherlands).
Immunohistochemistry
Paraffin sections of testes, 5 m thick, were mounted together on a silane-coated slide. At least three separate series of animals were used. Unmasking of cyclin The avidin-biotin complex reaction was performed according to the manufacturer's protocol. To visualize bound antibodies, sections were washed in PBS and covered with 0.3 g/l 3, 3Ј diaminodibenzene (DAB, Sigma) in PBS, to which 0.03% H 2 O 2 was added. Sections were counterstained with Mayers hematoxylin.
In negative control sections, the cyclin D 2 and cyclin D 3 antibodies were incubated with fivefold excess of cyclin D 2 and cyclin D 3 protein, respectively (Santa Cruz Biotechnologies), prior to use in the immunohistochemical analysis. Negative control sections for cyclin D 1 were treated as described earlier except that the primary antibody was omitted during the procedure and was replaced by normal mouse serum.
In adult testes immunohistochemically stained for cyclin D 2 , in random tubular cross-sections in stages VII and VIII of the cycle of the seminiferous epithelium, a total of 50 A spermatogonia were studied in each of three mice to establish the percentage of cyclin D 2 -positive A spermatogonia. In testes of fetal and newborn mice, immunohistochemically stained for cyclin D 1 , D 2 , and D 3 , in each of three mice, 100 gonocytes were scored at random to establish the percentage of positive staining gonocytes.
RESULTS
Localization of Cyclins D 1 , D 2 , and D 3 in the Adult Testis
Immunohistochemistry was performed to localize the different D-type cyclins in spermatogenic cell types. Staining for cyclin D 1 was seen in nuclei of spermatogonia in all stages of the cycle of the seminiferous epithelium (Fig.  1, A and B ; Table 1 ). In addition, Leydig cells showed a light nuclear cyclin D 1 staining. When the primary antibody was omitted and replaced by normal mouse serum, no staining was observed (Fig. 1G) .
Cyclin D 2 staining was observed in nuclei of A-sper- matogonia present in stages VII and VIII of the cycle of the seminiferous epithelium (Fig. 1C) . In these stages, about 39% Ϯ 2% of the A-spermatogonia were stained. In other stages of the cycle of the seminiferous epithelium only a very weak staining in a few spermatogonia could be detected. Furthermore, cyclin D 2 was clearly present in nuclei of pachytene spermatocytes from stage IV onward and, although very weakly, in nuclei of round spermatids until stage V of the cycle of the seminiferous epithelium (Fig.  1C , Table 1 ). In addition, a weak cyclin D 2 staining was present in the cytoplasm of these cells. In Sertoli and Leydig cells, no staining for cyclin D 2 was observed. Incubation of the primary antibody with a fivefold excess of cyclin D 2 protein resulted in a complete loss of staining (Fig. 1H) .
Immunohistochemical staining for cyclin D 3 was seen in the nuclei of some of the spermatogonia present in all stages of the cycle of the seminiferous epithelium ( Fig. 1F ; Table 1 ). Cyclin D 3 staining was also detected in the sex vesicle of pachytene and diplotene spermatocytes from stage VII until stage XI of the cycle of the seminiferous epithelium (Fig. 1F) . In addition, a clear cyclin D 3 staining was seen in nuclei of all Sertoli cells (Fig. 1F) . Finally, about 70% of the Leydig cells stained for cyclin D 3 . When the primary antibody was incubated with a fivefold excess of cyclin D 3 protein, no staining was observed (Fig. 1I) .
Cyclin D 2 Expression in Vitamin A-Deficient Testes
The immunohistochemical results suggested a role for cyclin D 2 in the differentiation of undifferentiated spermatogonia. To investigate this in further detail, the vitamin A deficiency model was used. Vitamin A deficiency in the mouse results in a spermatogenic block at the moment at which the undifferentiated spermatogonia start to differen- tiate into A 1 spermatogonia [28] [29] [30] . After all-trans retinoic acid treatment, spermatogenesis resumes, resulting in the formation of A 1 spermatogonia within 24 h [31] . To investigate the expression of cyclin D 2 before and during the time when undifferentiated spermatogonia differentiate into A 1 spermatogonia, immunohistochemistry was performed on the VAD testis and 24 h after retinoic acid injection. In the VAD testis, cyclin D 2 staining was present only in the cytoplasm of Sertoli cells (Fig. 1D) . No nuclear cyclin D 2 staining was present in either somatic or germ cells. However, 24 h after retinoic acid injection, nuclear cyclin D 2 staining was clearly present in about 30% of the spermatogonia (Fig. 1E) . Cyclin D 2 staining in the cytoplasm of Sertoli cells remained but seemed weaker.
Localization of Cyclin D 1 , D 2 , and D 3 During Testicular Development
During testicular development, very weak if any cyclin D 1 staining was observed in nuclei of proliferating and quiescent gonocytes from E14 until Day 3 postpartum (pp; Fig.  2A ). At Day 4 pp, cyclin D 1 staining was present in the nucleus of 56% Ϯ 2.4% of the gonocytes (Fig. 2B) . However, the nuclei of proliferating Sertoli cells and Leydig cells did not stain for cyclin D 1 , although the cytoplasm of both these cell types was lightly stained.
Cyclin D 2 staining also was not present in the nuclei of gonocytes from E14 until Day 3 pp (Fig. 2D) , however, some gonocytes showed a cytoplasmic cyclin D 2 staining at E17. In Leydig cells too, cyclin D 2 staining was present in the cytoplasm. From Day 3 pp onward, cyclin D 2 staining was observed in the nuclei of 39% Ϯ 7.5% of the gonocytes (Fig. 2E) . At this time, Sertoli cells and Leydig cells also showed a weak nuclear staining for cyclin D 2 .
Cyclin D 3 staining was present in nuclei of germ cells, pre-Sertoli cells, and pre-Leydig cells from E14 onward until at least Day 4 pp. However, whereas before birth all gonocytes were stained for cyclin D 3 (Fig. 2G) , at Days 3 and 4 only 75% Ϯ 6.7% of the gonocytes were stained (Fig. 2H ). In addition, large numbers of Leydig cells and Sertoli cells were stained for cyclin D 3 during testicular development.
No staining was observed in the control sections for cyclins D 1 , D 2 , and D 3 (Fig. 1, C, F, and I) . In control sections for cyclin D 1 staining, the primary antibody was omitted and replaced by normal mouse serum. In control sections for cyclins D 2 and D 3 staining, the primary antibody was incubated with a fivefold excess of cyclin D 2 or cyclin D 3 protein, respectively.
DISCUSSION
Using immunohistochemical analysis we were able to detect the three D-type cyclins in the testis. It is interesting that the expression patterns of cyclins D 1 , D 2 , and D 3 were only partly overlapping, suggesting different roles for these proteins during spermatogenesis.
During testicular development, both proliferating (E14.5, E15.5) and quiescent (E16.5 until after birth) gonocytes express only cyclin D 3 . When the gonocytes start to proliferate again after birth and form A 1 spermatogonia, a clear nuclear expression of cyclins D 1 , D 2 , and D 3 in gonocytes, or newly formed A 1 spermatogonia, or both, was observed.
In adult testis, cyclins D 1 and D 3 are expressed in some of the spermatogonia throughout the stages of the cycle of the seminiferous epithelium, suggesting that these cyclins are involved in the regulation of the proliferation of spermatogonia. However, cyclin D 2 is expressed only in spermatogonia in epithelial stages VII and VIII, when undifferentiated spermatogonia differentiate into differentiating spermatogonia [20] , suggesting that cyclin D 2 is involved in this differentiation step. To further investigate this possibility, VAD mice were used. Vitamin A deficiency results in a block in spermatogenesis just at the time when undifferentiated spermatogonia differentiate into A 1 spermatogonia [28] [29] [30] . After administration of retinoic acid there is a massive differentiation of undifferentiated spermatogonia into A 1 spermatogonia [31] . It is interesting that the undifferentiated spermatogonia in VAD mice did not show cyclin D 2 staining, whereas 24 h after retinoic acid injection, a clear staining in some of the spermatogonia was observed, again showing that cyclin D 2 is specifically expressed at the time that A 1 spermatogonia are formed. Hence, the expression patterns of cyclin D 2 at the start of spermatogenesis, in epithelial stages VII/VIII in the adult testis, and in the VAD/vitamin A replacement model all indicate that cyclin D 2 is involved in the process of differentiation of undifferentiated spermatogonia into A 1 spermatogonia. The formation of A 1 spermatogonia is an important event during spermatogenesis because the timed formation of these cells is the basis for the cycle of the seminiferous epithelium [20] . Another instance in which cyclin D 2 seems to be involved in a differentiation process is the cerebellum [32] , showing that cyclin D 2 is also involved in the induction of differentiation in other cell types.
Spermatocytes and spermatids expressed both cyclins D 2 and D 3 . Cyclin D 2 is expressed in nuclei of pachytene spermatocytes, which at that time, are in the prophase of the first meiotic division. Hence, cyclins D 2 and D 3 , as many other cell cycle proteins (e.g., p21 Cip1/WAF1 [33] and cyclin B 2 [34] ), may be necessary during the meiotic process.
During testicular development, somatic cells such as Sertoli cells and Leydig cells clearly expressed cyclin D 3 in their nuclei, while shortly after birth cyclin D 2 was also present. In the adult testis, the terminally differentiated Sertoli cells did not show expression of cyclin D 1 or D 2 protein. Lack of cyclin D 1 expression was surprising because results of Ravnik and colleagues [24] showed that Sertoli cells in the adult mouse testis express cyclin D 1 mRNA, as determined by in situ hybridization and Northern blot analysis. It is possible that the expression level of cyclin D 1 protein in Sertoli cells is too low to detect using immunohistochemistry because of low translational activity or a high turnover of the cyclin D 1 protein in these cells. In contrast, cyclin D 3 was clearly expressed in differentiated Sertoli cells and in Leydig cells, which do not or rarely proliferate, respectively. So, as in quiescent gonocytes, these results also suggest that cyclin D 3 can have a role not related to cell proliferation. Indeed, cyclin D 3 expression has also been observed in other quiescent cell types and in terminally differentiated cells in the gastrointestinal tract [5] .
Overall, the expression patterns of cyclin D 2 protein in both adult and developing testes are comparable with the cyclin D 2 mRNA localization studies of Nakayama et al. [25] . While in these studies a high cyclin D 2 mRNA expression was found in spermatogonia, cyclin D 2 levels below the in situ hybridization detection level may be present in pachytene spermatocytes. Ravnik et al. [24] previously found cyclin D 3 mRNA in round spermatids and Zhang and colleagues [27] found cyclin D 3 protein in some spermatogonia both during testicular development and in the adult testis, spermatocytes, spermatids, and Sertoli cells. These results in the adult testis but not in the developing testis were comparable to ours and indeed they also noted that cyclin D 3 may have dual functions during spermatogenesis: regulation of proliferation in spermatogonia and a role in non-cell cycle functions such as specialized morphogenetic differentiation, chromatin remodeling, or both.
It is important to note that the function of D-type cyclins may depend on the levels of other proteins. Robker et al. [35] found that the levels of cyclin D 2 relative to those of p27 Kip1 are important for granulosa cell development. Granulosa cell proliferation is induced by increasing levels of cyclin D 2 relative to p27 Kip1 and follicular growth is terminated by down-regulation of cyclin D 2 and up-regulation of p21 Cip1/WAF1 and p27 Kip1 . In addition, p27 Kip1 levels are also important for the onset of differentiation or cell cycle arrest in several cell types, including oligodendrocytes [36] , while cyclin D 2 overexpression in fibroblasts can shorten the G 1 phase of the cell cycle [3] . In adult testis, cyclin D 2 is colocalized with p21 Cip1/WAF1 in pachytene spermatocytes and cyclin D 3 with p27 Kip1 in Sertoli cells, suggesting that the balance between a D-type cyclin and a Cip/Kip family member may also be important in the behavior of these cell types. Similar colocalizations were observed during testicular development in gonocytes when they start to proliferate after birth [21] , correlating with cyclin D 2 induction and loss of p27 Kip1 [37] .
In conclusion, testicular expression of cyclin D 1 and also partially of cyclin D 3 correlates with G 1 /S progression of gonocytes and spermatogonia. However, cyclins D 2 and D 3 also likely have other functions in the testis. Cyclin D 2 likely plays a specific role in the differentiation program of undifferentiated spermatogonia into A 1 spermatogonia and may have a role during the meiotic prophase, in particular in pachytene spermatocytes. The role of cyclin D 3 in nonproliferating cells has, as yet, not been elucidated, but possibly relates to maintenance of the terminal state of cells. This clearly needs further study.
